# Commission Regulation (EC) No 983/2009 of 21 October 2009 on the authorisation and refusal of authorisation of certain health claims made on food and referring to the reduction of disease risk and to children’s development and health (Text with EEA relevance), Annex II

Extent: E+W+S+N.I.

REJECTED HEALTH CLAIMS
Application – Relevant provisions of Regulation (EC) No 1924/2006
Nutrient, substance, food or food category
Claim
EFSA opinion reference
Article 14(1)(a) health claim referring to reduction of disease risk
NeOpuntia®
NeOpuntia® helps to improve blood lipid parameters associated with cardiovascular risks, especially the HDL-cholesterol
EFSA-Q-2008-214
Article 14(1)(a) health claim referring to reduction of disease risk
Lactobacillus helveticus fermented Evolus®low-fat milk products
Evolus® reduces arterial stiffness
EFSA-Q-2008-218
Article 14(1)(b) health claim referring to children’s development and health
regulat®.pro.kid IMMUN
regulat®.pro.kid IMMUN supports, stimulates and modulates the immune system of children during growth
EFSA-Q-2008-082
Article 14(1)(b) health claim referring to children’s development and health
Dairy products
Three portions of dairy food everyday, as part of a balanced diet, may help promote a healthy body weight during childhood and adolescence
EFSA-Q-2008-110
Article 14(1)(b) health claim referring to children’s development and health
Dairy products
Dairy foods (milk & cheese) promote dental health in children
EFSA-Q-2008-112
Article 14(1)(b) health claim referring to children’s development and health
Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA)
DHA and ARA support neural development of the brain and eyes
EFSA-Q-2008-120
Article 14(1)(b) health claim referring to children’s development and health
regulat®.pro.kid BRAIN
regulat®.pro.kid BRAIN contributes to mental and cognitive development of children
EFSA-Q-2008-083
Article 14(1)(b) health claim referring to children’s development and health
Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA)
Calming
EFSA-Q-2008-091 and
EFSA-Q-2008-096
Article 14(1)(b) health claim referring to children’s development and health
Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA)
Provide serenity and room for a beneficial development of the child
EFSA-Q-2008-092 and
EFSA-Q-2008-097
Article 14(1)(b) health claim referring to children’s development and health
Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA)
Help to support vision
EFSA-Q-2008-095 and
EFSA-Q-2008-100
Article 14(1)(b) health claim referring to children’s development and health
Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA)
Help to support mental development
EFSA-Q-2008-098 and
EFSA-Q-2008-104
Article 14(1)(b) health claim referring to children’s development and health
Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA)
Help to promote concentration
EFSA-Q-2008-094 and
EFSA-Q-2008-099
Article 14(1)(b) health claim referring to children’s development and health
Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA)
Helps to promote the thinking capacity
EFSA-Q-2008-093 and
EFSA-Q-2008-101
Article 14(1)(b) health claim referring to children’s development and health
Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA)
Help to support the learning ability
EFSA-Q-2008-102 and
EFSA-Q-2008-103

---
Source: https://www.legislation.gov.uk/eur/2009/983/annex/II (the official version)
Page: https://openlegislation.uk/eu-regulation-2009-983/annex-II
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.